Trade

with

Endologix Inc
(NASDAQ: ELGX)
AdChoices
11.41
+0.08
+0.71%
After Hours :
11.41
0.00
0.00%

Open

11.43

Previous Close

11.33

Volume (Avg)

162.25k (574.07k)

Day's Range

11.34-11.46

52Wk Range

10.29-18.85

Market Cap.

758.58M

Dividend Rate ( Yield )

-

Beta

1.05

Shares Outstanding

66.95M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
Industry Medical Instruments & Supplies
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 132.26M

    • Net Income

    • -16.07M

    • Market Cap.

    • 758.58M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -11.49

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • 1.05

    • Forward P/E

    • -28.49

    • Price/Sales

    • 5.10

    • Price/Book Value

    • 5.30

    • Price/Cash flow

    • -103.09

      • EBITDA

      • -13.41M

      • Return on Capital %

      • -7.42

      • Return on Equity %

      • -13.28

      • Return on Assets %

      • -7.42

      • Book Value/Share

      • 2.15

      • Shares Outstanding

      • 66.95M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/21/2014
      Outperform
        • 1 Year Price Target

        • 15.25

        • Credit Rating

        • -

        • Analysts

        • 2

        • EPS Estimate

        • -0.40

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • 12.80

          • 10.42

          • Net Income

            YTD/YTD (last year)

          • -

          • -15.59

          • Net Income

            Q/Q (last year)

          • -

          • -8.93

          • Sales (Revenue)

            5-Year Annual Average

          • 28.56

          • 12.51

          • Net Income

            5-Year Annual Average

          • -

          • 4.16

          • Dividends

            5-Year Annual Average

          • -

          • 0.97

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • 74.79

            • 52.83

            • Pre-Tax Margin

            • -11.54

            • 15.96

            • Net Profit Margin

            • -11.49

            • 12.40

            • Average Gross Margin

              5-Year Annual Average

            • 76.30

            • 52.66

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 18.40

            • Average Net Profit Margin

              5-Year Annual Average

            • -13.80

            • 93.46B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • 0.48

              • 0.62

              • Current Ratio

              • 5.97

              • 1.97

              • Quick Ratio

              • 4.84

              • 1.16

              • Interest Coverage

              • -4.12

              • 10.47

              • Leverage Ratio

              • 1.83

              • 2.38

              • Book Value/Share

              • 2.15

              • 12.15

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -44.84

                • 36.10

                • P/E Ratio 5-Year High

                • -73.38

                • 279.08

                • P/E Ratio 5-Year Low

                • -12.85

                • 148.87

                • Price/Sales Ratio

                • 5.15

                • 3.37

                • Price/Book Value

                • 5.35

                • 4.21

                • Price/Cash Flow Ratio

                • -103.09

                • 17.42

                • Key Metrics

                • Company

                • Industry

                  • Return on Equity %

                    (5-Year Average)

                  • -13.28

                    (-16.60)

                  • 17.93

                    (21.42)

                  • Return on Assets %

                    (5-Year Average)

                  • -7.42

                    (-9.50)

                  • 7.35

                    (9.50)

                  • Return on Capital %

                    (5-Year Average)

                  • -6.81

                    (-15.40)

                  • 10.24

                    (13.59)

                  • Income/Employee

                  • -

                  • 25.65k

                  • Inventory Turnover

                  • 1.54

                  • 2.66

                  • Asset Turnover

                  • 0.65

                  • 0.59

                  Current Historical
                  Financials
                  • Income Statement
                  • Balance Sheet
                  • Cash Flow
                  Operating Income
                  -10.37M
                  Operating Margin
                  -7.84
                  Total Equity
                  -
                  Retained Earnings
                  -
                  Free Cashflow
                  -
                  Price/Cashflow
                  -103.09
                  Ownership

                  Institutional Ownership

                  -

                  Top 10 Institutions

                  48.65%

                  Mutual Fund Ownership

                  55.69%

                  Float

                  98.28%

                  5% / Insider Ownership

                  3.39%

                  Corporate insiders or major stockholders reporting trading activity in the stock.

                  Top Mutual Fund Owners

                  Top Institutional Owners

                  Mutual Fund Name

                  Institution Name

                  • Mutual Fund Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Janus Triton Fund

                  •  

                    3,570,445

                  • 11.54

                  • 5.34

                  • Janus Venture Fund

                  •  

                    1,893,319

                  • 14.34

                  • 2.83

                  • ClearBridge Small Cap Growth Fund

                  •  

                    1,878,467

                  • -1.05

                  • 2.81

                  • Meridian Growth Fund

                  •  

                    1,627,355

                  • 26.99

                  • 2.43

                  • Goldman Sachs Small Cap Value

                  •  

                    1,305,762

                  • -18.67

                  • 1.95

                  • Janus Global Life Sciences Fund

                  •  

                    1,159,609

                  • 6.13

                  • 1.73

                  • Vanguard Small Cap Index

                  •  

                    1,105,660

                  • 4.33

                  • 1.65

                  • Vanguard Total Stock Mkt Idx

                  •  

                    1,004,191

                  • 2.43

                  • 1.50

                  • Polar Capital Healthcare Opps

                  •  

                    1,000,000

                  • 0.00

                  • 1.49

                  • iShares Russell 2000 (AU)

                  •  

                    953,666

                  • -1.46

                  • 1.52

                  • Institution Name

                  • Shares Held

                  • % Change

                  • % Outstanding

                  • Janus Capital Management LLC

                  •  

                    7,701,898

                  • +9.72%

                  • 11.51

                  • Vanguard Group, Inc.

                  •  

                    3,678,180

                  • -0.75%

                  • 5.50

                  • Essex Woodlands Health Ventures

                  •  

                    2,814,936

                  • +141.54%

                  • 4.21

                  • Arrowpoint Asset Management, LLC

                  •  

                    2,514,546

                  • +89.10%

                  • 3.76

                  • Goldman Sachs Asset Management, L.P.

                  •  

                    2,376,891

                  • +5.44%

                  • 3.55

                  • Tamarack Capital Management, LLC

                  •  

                    2,375,000

                  • +66.67%

                  • 3.55

                  • MFS Investment Management K.K.

                  •  

                    2,309,078

                  • -49.64%

                  • 3.45

                  • Palisade Capital Management LLc

                  •  

                    2,198,877

                  • -2.88%

                  • 3.29

                  • ClearBridge Advisors, LLC

                  •  

                    2,092,872

                  • +0.34%

                  • 3.13

                  Company Profile

                  Sector

                  Healthcare

                  Industry

                  Medical Instruments & Supplies

                  Type

                  Speculative Growth

                  Style

                  Small Growth

                  Endologix Inc was incorporated in California on March 16, 1992 under the name Cardiovascular Dynamics, Inc. and reincorporated in Delaware in June 1993. The Company develops, manufactures, markets and sells medical devices for the tr...moreeatment of abdominal aortic aneurysms (AAA). Its main products are intended for the treatment of AAA through minimally-invasive endovascular repair (EVAR) or endovascular sealing ('EVAS'), solution for sealing the aneurysm sac while maintaining blood flow through two blood flow lumens. Once AAA develops, it continues to enlarge and, if left untreated, becomes increasingly susceptible to rupture. The Company's EVAR products consist of: a cobalt chromium alloy stent covered by polytetrafluoroethylene graft material; and an accompanying delivery system. The Company's EVAS p...moreroduct consists of: bilateral covered stents with endobags; a biocompatible polymer injected into the endobags to seal the aneurysm; and a delivery system and polymer dispenser. All of its products are manufactured, assembled, and packaged at its 60,000 square foot leased facilities in Irvine, California and markets and sells its products in the U.S. and in 11 Western European countries through a direct sales force and network of agents. The Company sells EVAR products through exclusive independent distributors or agents in 14 other European countries, Japan, 9 countries in South America, New Zealand and Mexico. Its main competitors include: Medtronic, Inc., W.L. Gore Inc., and Cook Medical Products, Inc., and new market entrants, TrvVascular, Inc. and Lombard Medical Technologies. The Company is subject to additional licensing and regulatory requirements relating to safe working conditions, manufacturing practices, environmental protection, fire hazard control, and disposal of hazardous or potentially hazardous substances.lessless

                  Key People

                  John McDermott

                  CEO/Chairman of the Board/Director

                  Shelley B. Thunen

                  CFO/Secretary

                  Joseph DeJohn

                  Vice President, Divisional

                  Janet Fauls

                  Vice President, Divisional

                  Mr. Todd Abraham

                  Vice President, Divisional

                  • Endologix Inc

                  • 11 Studebaker

                  • Irvine, CA 92618

                  • USA.Map

                  • Phone: +1 949 595-7200

                  • Fax: -

                  • endologix.com

                  Incorporated

                  1992

                  Employees

                  482

                  Send Feedback

                  We appreciate your input!

                  • I'm having trouble signing into my Microsoft account

                  • I’m having problems with the services stripe (Mail, Facebook, etc.)

                  • There is an issue with my weather information

                  • I see an error in the content

                  • Other

                  Please give an overall site rating: